Furthermore, we document that a dual p300/BRD4 inhibitor NEO273452,53 suppressed T-ALL cell growth with a 3–10-fold lower IC50 compared to JQ1 or CCS1477 alone (Fig. 4l). The gene discussed is BRD4; the disease is acute lymphoblastic leukemia.